TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

News

Brief news reports on Tuberculosis

Epistem expected to sign more partners as TB test gets European approval, says broker

Stem cell specialist Epistem is likely to sign more partners for its Genedrive diagnostic platform, after being granted a CE mark as an in-vitro diagnostic medical device, reckons broker Peel Hunt.

Read More →

South Africa: Hospital TB infections ‘rife’

Twelve percent of staff tested at KwaZulu-Natal’s biggest government-funded tuberculosis hospitals are infected with the disease because none of these facilities employ occupational health officers, say researchers.

Read More →

South Africa: Clinic shows how to cut maternal deaths

Cape Town — In a country where deaths from pregnancy and childbirth have been rising - more than four-fold in a decade, according to reports - not a single maternal death was recorded at a maternal obstetric unit in Khayelitsha, a poor settlement outside Cape Town, from April 2011 to May this year.

Read More →

Turn The Tide: Treat HIV and cure TB

Despite the fact that TB is curable and HIV is treatable, an estimated 8.5 million new and relapsed TB cases were reported in 2010, and an estimated 1.4 million died, which included 350,000 people living with HIV and co-infected with TB.

Read More →

Web-based training course "Introduction to MDR-TB clinical management"

The DR TB Training Network https://drtbnetwork.org/is pleased to announce and invite you to the web-based training course Introduction to MDR-TB Clinical Management, 10 – 26 July 2012, the aim of which is to provide doctors, nurses and clinical officers working in resource-limited settings with basic clinical knowledge on how to initiate and treat MDR-TB patients. To participate visit the DR TB Training Network https://drtbnetwork.org/webinars and register for as many of the webinars as you would like.

Read More →

FP7 Health partner search for tuberculosis drug development

American SME Sequella Inc. is looking for partners for preclinical and early clinical development of new drug candidates for the treatment of multidrug-resistant tuberculosis (MDR-TB) under FP7 (or even Eurostars).

Read More →

UK: Drug-resistant cases of tuberculosis on the rise

Drug-resistant cases of tuberculosis (TB) are on the rise in the UK, figures suggest.

Read More →

CDC Grand Rounds: the TB/HIV syndemic

This is another in a series of occasional MMWR reports titled CDC Grand Rounds. These reports are based on grand rounds presentations at CDC on high-profile issues in public health science, practice, and policy. Information about CDC Grand Rounds is available at http://www.cdc.gov/about/grand-rounds.

Read More →

EMA: Response to TB CAB letter

EMA's response to TB CAB letter regarding conducting drug-drug interaction studies for bedaquiline (TMC207) and delamanid (OPC6783).

Read More →

Experiment eleven: Deceit and betrayal in the discovery of the cure for tuberculosis by Peter Pringle – review

The story of the lone heroic medical researcher who conquers a terrible disease is a cherished archetype: the long struggle, the countless unproductive experiments, the risk to the researcher, and above all that solitary, driven quest. We love this narrative so much that we will it into being, often at odds with the truth. One name, Alexander Fleming, will always be synonymous with penicillin, but for 13 years after Fleming discovered it, penicillin was going nowhere. The effective drug derived from that famous mould was developed under wartime pressure by a large team headed by Howard Florey and Ernst Chain. All three were rightly awarded the Nobel prize, but it doesn't matter how often I or anyone else says this, in the popular imagination the word penicillin will always conjure up Fleming and that stray contaminated Petri dish left on a lab bench.

Read More →

Page 823 of 895 · Total posts: 10

←First 822 823 824 Last→